 |
|
teniposide
A semisynthetic derivative of podophyllotoxin with antineoplastic activity. Teniposide forms a ternary complex with the enzyme topoisomerase II and DNA, resulting in dose-dependent single- and double-stranded breaks in DNA, DNA: protein cross-links, inhibition of DNA strand religation, and cytotoxicity. This agent acts in the late S or early G phase of the cell cycle. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | Thenvlidene-Lignan-P
Thenylidene-Lignan-P
VM26 | | | | US brand name: | | Vumon | | | | Foreign brand name: | | Vehem | | | | Abbreviations: | | EPT
PTG | | | | Code name: | | VM-26 | | | | Chemical structure names: | | - [5R-[5Alpha,5a beta,8a alpha, 9beta(R*)]]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-9-[[4,6-O-(2-thienylmethylene)-beta-D-glucopyranosyl]oxy]furo[3',4':6,7]-naphtho[2,3-d]-1,3-dioxol-6(5aH)-one
- 4'-Demethylepipodophyllotoxin 9-(4,6-O-2-Thenylidene-beta-D-glucopyranoside)
- 4'-Demethylepipodophyllotoxin-beta-D-thenylidine Glucoside
| | |
|
|
